Dermira, Inc.

Biomed Valley Discoveries, Inc.

Journey Medical Corporation

Albany Molecular Research, Inc.

Salix Pharmaceuticals, Inc.

Amri Ssci, LLC

Jon Gordon Selbo

Patricia Andres

Mark Andres

Jennifer Leigh Nelson

Anthony Adrian Shaw

Delphine Caroline Imbert

Lisa Lynn McQueen

Stephan Xander Mattheus Boerrigter

John Allan Statler

Ekaterina Albert

Dean Welsch

Gary DeCrescenzo

Emily Marie Rigsbee

Jing Teng

Mohammed A Kabir

Pam Golden

Shital Viral Mehta

Yizheng Cao

Mark Christopher Andres

Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Glycopyrrolate salts

Described herein are cocrystals of epigallocatechin gallate (ECGC) and caffeine, compositions comprising such cocrystals, methods of making such cocrystals, and methods of improving animal or human health by treating with such cocrystals. In particular, Form I and Form II of a 1:2 (epigallocatechin gallate to caffeine) cocrystal are described.

Polymorphs of cocrystals of epigallocatechin gallate and caffeine

The present invention provides a malonate salt of a compound of formula (I): which is a crystalline salt. Also provided are pharmaceutical compositions that include the provided malonate salt and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer.

[object Object]

The present invention relates to new rifaximin forms comprising solid dispersions of rifaximin, methods of making same and to their use in medicinal preparations and therapeutic methods.

Formulations of rifaximin and uses thereof

Growing community of inventors

West Lafayette, IN, United States of America

Jon Gordon Selbo